02366oam 2200733 450 991071697030332120211103142540.070-300 O(CKB)5470000002526491(OCoLC)609101323(OCoLC)608084585(OCoLC)1011782402(OCoLC)1022006588(OCoLC)1069498955(EXLCZ)99547000000252649120100423g19809999 ua 0engurbn||||||abpurbn||||||adatxtrdacontentcrdamediacrrdacarrierDrug regulation reform--oversight hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ..Washington :U.S. G.P.O.,1980-1 online resourceAccess ID (govinfo): CHRG-96hhrg70300Ov2."Serial no. 96-170.""Serial no. 96-216."v. 1. New drug approval process -- v. 2. Orphan drugs.Drug regulation reform--oversight Pharmaceutical policyUnited StatesDrugsUnited StatesTestingPharmaceutical industryUnited StatesDrug IndustryPharmaceutical PreparationsstandardsResearchstandardsDrugsTestingfastPharmaceutical industryfastPharmaceutical policyfastUnited StatesUnited StatesfastLegislative hearings.lcgftPharmaceutical policyDrugsTesting.Pharmaceutical industryDrug Industry.Pharmaceutical Preparationsstandards.Researchstandards.DrugsTesting.Pharmaceutical industry.Pharmaceutical policy.OCLCEOCLCEOCLCQOCLCFOCLCOOCLCAOCLCQNJROCLCQOCLCAUWOOCLCQGPOBOOK9910716970303321Drug regulation reform--oversight3536321UNINA